Analyst Ratings for Jazz Pharmaceuticals (JAZZ)
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $307.00 (UBS)
- Lowest: $226.00 (Deutsche Bank)
- Average: $257.82
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$257.82 (+14.8%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
Avg. $ Target:
$257.82 (+14.8%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/9/2026 | Truist Securities | Gregory Renza | New Coverage | Buy (N/A) |
256.00 (N/A) |
232.04 (224.66) |
-3.18% | Details |
| 5/21/2026 | Bernstein SocGen Group » Updated 6/9/2026 |
Jeffrey Walch | New Coverage | Market Perform (N/A) |
229.00 (N/A) |
239.01 (224.66) |
-6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
